279 related articles for article (PubMed ID: 10673637)
21. [Myeloid growth factors can cure chronic neutropenia and facilitate cytostatic therapy].
Palmblad J; Samuelsson J
Lakartidningen; 1992 Mar; 89(13):1037-8, 1041. PubMed ID: 1372671
[No Abstract] [Full Text] [Related]
22. Hematopoietic growth factors and high-dose chemotherapy: will grams succeed where milligrams fail?
Demetri GD; Griffin JD
J Clin Oncol; 1990 May; 8(5):761-4. PubMed ID: 1692086
[No Abstract] [Full Text] [Related]
23. Hematopoietic growth factors--not whether, but when and where.
Hoelzer D
N Engl J Med; 1997 Jun; 336(25):1822-4. PubMed ID: 9187075
[No Abstract] [Full Text] [Related]
24. [The dilemma of stimulating factors in the recovery from chemotherapeutic neutropenia].
Borbollo Escoboza JR; González Avante M; Alvarado Ibarra M
Rev Invest Clin; 1996; 48(4):328. PubMed ID: 8966397
[No Abstract] [Full Text] [Related]
25. Clinical uses of hematopoietic growth hormones in HIV-related illnesses.
Mitsuyasu RT
AIDS Clin Rev; 1993-1994; ():189-212. PubMed ID: 7692940
[No Abstract] [Full Text] [Related]
26. [The strategy for chemotherapy-induced myelosuppression].
Hangaishi A
Gan To Kagaku Ryoho; 2011 Nov; 38(11):1777-81. PubMed ID: 22083184
[TBL] [Abstract][Full Text] [Related]
27. [The use of erythropoietin alpha in programs of high-dose chemotherapy].
Danova M; Aglietta M; Pierelli L; Ferrari S; Perillo A; Scambia G; Henry D
Recenti Prog Med; 2000 Dec; 91(12):681-9. PubMed ID: 11194490
[TBL] [Abstract][Full Text] [Related]
28. [Filgrastim--a hematopoietic growth factor (r-metHuC-CSF) for treatment of neutropenia caused by cytostatics].
Ersbøll J
Ugeskr Laeger; 1991 Sep; 153(38):2647-50. PubMed ID: 1719682
[No Abstract] [Full Text] [Related]
29. [Management and types of side effects in chemotherapy for lung cancer].
Yoshida K
Nihon Rinsho; 2002 May; 60 Suppl 5():384-7. PubMed ID: 12101694
[No Abstract] [Full Text] [Related]
30. [Growth factors in oncology: effectiveness and prospects].
Ottmann OG; Hoelzer D
Praxis (Bern 1994); 1998 Sep; 87(36):1153-9. PubMed ID: 9782744
[TBL] [Abstract][Full Text] [Related]
31. Disappointments in treating acute leukemia in the elderly.
Hamblin TJ
N Engl J Med; 1995 Jun; 332(25):1712-3. PubMed ID: 7539110
[No Abstract] [Full Text] [Related]
32. [Place of CSF in pediatric oncology].
Hartmann O; Valteau-Couanet D
Pathol Biol (Paris); 1993 Jan; 41(1):52. PubMed ID: 7686289
[No Abstract] [Full Text] [Related]
33. Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin.
Hofland KF; Thougaard AV; Sehested M; Jensen PB
Clin Cancer Res; 2005 May; 11(10):3915-24. PubMed ID: 15897593
[TBL] [Abstract][Full Text] [Related]
34. The benefits of haematopoietic growth factors in the management of gynaecological oncology.
Dale DC
Eur J Gynaecol Oncol; 2004; 25(2):133-44. PubMed ID: 15032269
[TBL] [Abstract][Full Text] [Related]
35. Hematopoietic growth factors for chemotherapy-induced neutropenia.
Yalçin S
Cancer Invest; 1999; 17(7):555-6. PubMed ID: 10518202
[No Abstract] [Full Text] [Related]
36. Colony-stimulating factors: clinical status.
Gabrilove JL
Important Adv Oncol; 1991; ():215-37. PubMed ID: 1714420
[No Abstract] [Full Text] [Related]
37. Should the indications for the use of myeloid growth factors for the prevention of febrile neutropenia in cancer patients be extended?
Klastersky J; Awada A; Aoun M; Paesmans M
Curr Opin Oncol; 2009 Jul; 21(4):297-302. PubMed ID: 19509500
[TBL] [Abstract][Full Text] [Related]
38. Granulocyte--colony-stimulating factor (Filgrastim) may overcome imatinib-induced neutropenia in patients with chronic-phase myelogenous leukemia.
Jørgensen HG; Copland M; Holyoake TL
Cancer; 2005 Jan; 103(1):210-11. PubMed ID: 15540243
[No Abstract] [Full Text] [Related]
39. Colony-stimulating factors stimulate some treatments, continue to evolve.
Volkers N
J Natl Cancer Inst; 1999 Feb; 91(3):210-2. PubMed ID: 10037097
[No Abstract] [Full Text] [Related]
40. [G-CSF in practice: malignant non-Hodgkin's lymphomas].
Rossi JF
Pathol Biol (Paris); 1993 Jan; 41(1):44-5. PubMed ID: 7686283
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
